Lundbeck
Lundbeck is a global pharmaceutical company specialized in brain diseases. For more than 70 years, we have been at the forefront of neuroscience research. We are tirelessly dedicated to restoring brain health, so every person can be their best.
An estimated 700 million people worldwide are living with brain diseases and far too many suffer due to inadequate treatment, discrimination, a reduced number of working days, early retirement and other unnecessary consequences. Every day, we strive for improved treatment and a better life for people living with brain diseases – we call this Progress in Mind.
In the U.S., Lundbeck employs more than 800 people focused solely on accelerating therapies for brain disorders. With a special commitment to the lives of patients, families and caregivers, Lundbeck U.S. actively engages in hundreds of initiatives each year that support our patient communities.
RELATED ARTICLES
There Are No Failures in Parkinson’s Research; Only Setbacks
Parkinson’s disease can’t be slowed or cured, but researchers like Dr. Williamson are working to cha…
READ MORE
Parkinson’s disease does not mean living with limits
Thanks to Parkinson’s Disease research and treatment advances, astronaut Rich Clifford continues to…
READ MORE
Pushing the boundaries of science to treat Parkinson’s disease
Biopharma researchers like Doug are fighting to give Parkinson's patients like Rich their normal liv…
READ MORETackling Neurological Disorders in New Ways
Chronic pain. Alzheimer's disease. Multiple Sclerosis. Brain tumors. These are some of the most well…
READ MORE
Disrupting Alzheimer's Disease
Researchers, patient advocates and policymakers recently gathered in Chicago to discuss the unique c…
READ MORE
Researcher Profile: Doug Williamson
In recognition of the great work being done to treat mental illness, we're sharing the story of Doug…
READ MORE
Tackling Neurological Disorders in New Ways
Chronic pain. Alzheimer's disease. Multiple Sclerosis. Brain tumors. These are some of the most well…
READ MORE
On the Cusp of A New Era In Mental Health Care
As a medical student, as soon as I saw the way that diseases like depression, schizophrenia and bipo…
READ MORE
No Stone Unturned in Mental Health Research
Treating patients with mental health disorders is about getting to know the person behind the diseas…
READ MOREPOPULAR ARTICLES
Can We Afford the New Era of Medicine?
Innovative treatments require innovative partnerships. America's Biopharmaceutical Companies and insurers are partnering to get the right medicine in the hands of patients who need them.
READ MORE
Researcher Profile: Jirong Lu
Dr. Jirong Lu, a distinguished research fellow at Eli Lilly and Company (Lilly), traces the beginnings of her career to a high school fascination with chemistry.
READ MORE
We Cannot Take Progress for Granted
We are in a new era of medical discovery and have the potential to revolutionize the treatment of costly and debilitating diseases. But we must not take this progress for granted.
READ MORE
The Greatest Gift of All: Hope
My son Parker's journey with juvenile arthritis (JA) began 10 years ago when he was in elementary school.
READ MORE
Migraine: More than Just a Bad Headache
Migraine is a debilitating neurological disease that is often misunderstood by those who do not suffer symptoms, according to the Migraine Impact Report, a new survey recently released by Eli Lilly and Company and conducted by Nielsen.
READ MORE
Washington is considering policy changes that could threaten innovation
New policy proposals in Washington threaten to hamstring investment in innovation and jeopardize breakthroughs.
READ MORE
Tackling Neurological Disorders in New Ways
Chronic pain. Alzheimer's disease. Multiple Sclerosis. Brain tumors. These are some of the most well-known and prevalent diseases afflicting the more than 100 million Americans who are impacted by a neurological disorder.
READ MORE